{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:49:55Z","timestamp":1787741395838,"version":"build-2784847793"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Circular RNAs (circRNAs) are a class of non-coding RNAs with a loop structure; however, their functions remain largely unknown. Growing evidence suggests that circRNAs play a pivotal role in the progression of malignant diseases. However, the expression profiles and function of circRNAs in hepatocellular carcinoma (HCC) remain unclear. We investigated the expression of microtubule-associated serine\/threonine kinase 1 (MAST1) circRNA (circMAST1) in HCC and healthy tissues using bioinformatics, quantitative real-time PCR (qRT-PCR), and fluorescence in situ hybridization. Luciferase reporter assays were performed to assess the interaction between circMAST1 and miR-1299. Proliferation assays, colony formation assays, flow cytometry, transwell assays, and western blotting were also performed. A mouse xenograft model was also used to determine the effect of circMAST1 on HCC growth in vivo. CircMAST1 was upregulated in HCC tissues and cell lines; silencing via small interfering RNA inhibited migration, invasion, and proliferation of HCC cell lines in vitro as well as tumor growth in vivo. Furthermore, the expression of circMAST1 was positively correlated with catenin delta-1 (CTNND1) and negatively correlated with microRNA (miR)-1299 in HCC clinical samples. Importantly, circMAST1 sponged miR-1299 to stabilize the expression of CTNND1 and promoted tumorigenic features in HCC cell lines. We found that circMAST1 may serve as a novel biomarker for HCC. Moreover, circMAST1 elicits HCC progression by sponging miRNA-1299 and stabilizing CTNND1. Our data provide potential options for therapeutic targets in patients with HCC.<\/jats:p>","DOI":"10.1038\/s41419-020-2532-y","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:03:39Z","timestamp":1589223819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The circular RNA circMAST1 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-1299 and regulating CTNND1 expression"],"prefix":"10.1038","volume":"11","author":[{"given":"Xiufeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiMeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"2532_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1459\u20131544 (2016).","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"2532_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"F C","year":"2019","unstructured":"C, F. et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncology 5, 1749\u20131768 (2019).","journal-title":"JAMA Oncology"},{"key":"2532_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4103\/1319-3767.151216","volume":"21","author":"AA Madkhali","year":"2015","unstructured":"Madkhali, A. A., Fadel, Z. T., Aljiffry, M. M. & Hassanain, M. M. Surgical treatment for hepatocellular carcinoma. Saudi J. Gastroenterol. 21, 11\u201317 (2015).","journal-title":"Saudi J. Gastroenterol."},{"key":"2532_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00432-002-0396-4","volume":"129","author":"Y Li","year":"2003","unstructured":"Li, Y. et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J. Cancer Res. Clin. Oncol. 129, 43\u201351 (2003).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2532_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","volume":"160","author":"SJ Conn","year":"2015","unstructured":"Conn, S. J. et al. The RNA binding protein quaking regulates formation of circRNAs. Cell 160, 1125\u20131134 (2015).","journal-title":"Cell"},{"key":"2532_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.omtn.2019.04.011","volume":"16","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. Emerging epigenetic regulation of circular RNAs in human cancer. Mol. Ther. Nucleic Acids 16, 589\u2013596 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2532_CR7","doi-asserted-by":"publisher","first-page":"9331","DOI":"10.3390\/ijms15069331","volume":"15","author":"H Suzuki","year":"2014","unstructured":"Suzuki, H. & Tsukahara, T. A view of pre-mRNA splicing from RNase R resistant RNAs. Int. J. Mol. Sci. 15, 9331\u20139342 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"2532_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384\u2013388 (2013).","journal-title":"Nature"},{"key":"2532_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li, Z. et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat. Struct. Mol. Biol. 22, 256\u2013264 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2532_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrm3967","volume":"16","author":"E Zlotorynski","year":"2015","unstructured":"Zlotorynski, E. & Non-coding RNA: circular RNAs promote transcription. Nat. Rev. Mol. Cell Biol. 16, 206 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2532_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","volume":"56","author":"R Ashwal-Fluss","year":"2014","unstructured":"Ashwal-Fluss, R. et al. circRNA biogenesis competes with pre-mRNA splicing. Mol. Cell 56, 55\u201366 (2014).","journal-title":"Mol. Cell"},{"key":"2532_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","volume":"12","author":"LL Chen","year":"2015","unstructured":"Chen, L. L. & Yang, L. Regulation of circRNA biogenesis. RNA Biol. 12, 381\u2013388 (2015).","journal-title":"RNA Biol."},{"key":"2532_CR13","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.7150\/thno.21299","volume":"7","author":"WW Du","year":"2017","unstructured":"Du, W. W. et al. Identifying and characterizing circRNA-protein interaction. Theranostics 7, 4183\u20134191 (2017).","journal-title":"Theranostics"},{"key":"2532_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","volume":"66","author":"I Legnini","year":"2017","unstructured":"Legnini, I. et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol. Cell 66, 22\u201337 e29 (2017).","journal-title":"Mol. Cell"},{"key":"2532_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1261\/rna.048272.114","volume":"21","author":"Y Wang","year":"2015","unstructured":"Wang, Y. & Wang, Z. Efficient backsplicing produces translatable circular mRNAs. RNA 21, 172\u2013179 (2015).","journal-title":"RNA"},{"key":"2532_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1031-1","volume":"18","author":"PF Zhang","year":"2019","unstructured":"Zhang, P. F. et al. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression. Mol. Cancer 18, 105 (2019).","journal-title":"Mol. Cancer"},{"key":"2532_CR17","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2018.01.012","volume":"68","author":"J Yu","year":"2018","unstructured":"Yu, J. et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J. Hepatol. 68, 1214\u20131227 (2018).","journal-title":"J. Hepatol."},{"key":"2532_CR18","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.7150\/thno.32796","volume":"9","author":"YJ Zhu","year":"2019","unstructured":"Zhu, Y. J. et al. Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma. Theranostics 9, 3526\u20133540 (2019).","journal-title":"Theranostics"},{"key":"2532_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.30795","volume":"71","author":"Y Wei","year":"2020","unstructured":"Wei, Y. et al. A noncoding regulatory RNAs network driven by Circ-CDYL acts specifically in the early stages hepatocellular carcinoma. Hepatology 71, 130\u2013147 (2020).","journal-title":"Hepatology"},{"key":"2532_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158347","volume":"11","author":"L Yu","year":"2016","unstructured":"Yu, L. et al. The circular RNA Cdr1as act as an oncogene in hepatocellular carcinoma through targeting miR-7 expression. PLoS ONE 11, e0158347 (2016).","journal-title":"PLoS ONE"},{"key":"2532_CR21","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1158\/0008-5472.CAN-17-3009","volume":"78","author":"J Meng","year":"2018","unstructured":"Meng, J. et al. Twist1 regulates vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma. Cancer Res. 78, 4150\u20134162 (2018).","journal-title":"Cancer Res."},{"key":"2532_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0204-3","volume":"9","author":"G Chen","year":"2018","unstructured":"Chen, G., Shi, Y., Liu, M. & Sun, J. circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma. Cell Death Dis. 9, 175 (2018).","journal-title":"Cell Death Dis."},{"key":"2532_CR23","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.2174\/1381612822666160303110838","volume":"22","author":"HR Mirzaei","year":"2016","unstructured":"Mirzaei, H. R. et al. Circulating microRNAs in hepatocellular carcinoma: potential diagnostic and prognostic biomarkers. Curr. Pharm. Des. 22, 5257\u20135269 (2016).","journal-title":"Curr. Pharm. Des."},{"key":"2532_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.556","volume":"8","author":"L Shi","year":"2017","unstructured":"Shi, L. et al. Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma. Cell Death Dis. 8, e3171 (2017).","journal-title":"Cell Death Dis."},{"key":"2532_CR25","doi-asserted-by":"publisher","first-page":"102854","DOI":"10.1016\/j.critrevonc.2019.102854","volume":"145","author":"P Naeli","year":"2020","unstructured":"Naeli, P. et al. Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role. Crit. Rev. Oncol. Hematol. 145, 102854 (2020).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2532_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0558-5","volume":"12","author":"Z Shabaninejad","year":"2019","unstructured":"Shabaninejad, Z. et al. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. J. Ovarian Res. 12, 84 (2019).","journal-title":"J. Ovarian Res."},{"key":"2532_CR27","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","volume":"20","author":"P Glazar","year":"2014","unstructured":"Glazar, P., Papavasileiou, P. & Rajewsky, N. circBase: a database for circular RNAs. RNA 20, 1666\u20131670 (2014).","journal-title":"RNA"},{"key":"2532_CR28","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/nm.2580","volume":"17","author":"DR Robinson","year":"2011","unstructured":"Robinson, D. R. et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat. Med. 17, 1646\u20131651 (2011).","journal-title":"Nat. Med."},{"key":"2532_CR29","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.neuron.2018.10.044","volume":"100","author":"R Tripathy","year":"2018","unstructured":"Tripathy, R. et al. Mutations in MAST1 cause mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations. Neuron 100, 1354\u20131368 (2018).","journal-title":"Neuron"},{"key":"2532_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ccell.2018.06.012","volume":"34","author":"L Jin","year":"2018","unstructured":"Jin, L. et al. MAST1 drives cisplatin resistance in human cancers by rewiring cRaf-independent MEK activation. Cancer Cell 34, 315\u2013330 (2018).","journal-title":"Cancer Cell"},{"key":"2532_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.canlet.2019.06.007","volume":"460","author":"YG Wang","year":"2019","unstructured":"Wang, Y. G. et al. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307. Cancer Lett. 460, 128\u2013138 (2019).","journal-title":"Cancer Lett."},{"key":"2532_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13046-019-1041-2","volume":"38","author":"L Xu","year":"2019","unstructured":"Xu, L. et al. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J. Exp. Clin. Cancer Res. 38, 98 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2532_CR33","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1038\/s41388-019-0699-4","volume":"38","author":"F Rossi","year":"2019","unstructured":"Rossi, F. et al. Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma. Oncogene 38, 3843\u20133854 (2019).","journal-title":"Oncogene"},{"key":"2532_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2018.05.033","volume":"430","author":"J Wu","year":"2018","unstructured":"Wu, J. et al. CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis. Cancer Lett. 430, 179\u2013192 (2018).","journal-title":"Cancer Lett."},{"key":"2532_CR35","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1158\/0008-5472.CAN-14-0787","volume":"75","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Chemotherapy-induced miRNA-29c\/catenin-delta signaling suppresses metastasis in gastric cancer. Cancer Res. 75, 1332\u20131344 (2015).","journal-title":"Cancer Res."},{"key":"2532_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.omtn.2019.05.005","volume":"17","author":"Y Liang","year":"2019","unstructured":"Liang, Y. et al. Targeting the circBMPR2\/miR-553\/USP4 axis as a potent therapeutic approach for breast cancer. Mol. Ther. Nucleic Acids 17, 347\u2013361 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2532_CR37","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1042\/CS20190394","volume":"133","author":"J Yu","year":"2019","unstructured":"Yu, J. et al. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p\/TXNDC5 signaling pathway. Clin. Sci. 133, 1487\u20131503 (2019).","journal-title":"Clin. Sci."},{"key":"2532_CR38","doi-asserted-by":"crossref","unstructured":"Chen, X. et al. Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA\/AMPKalpha signaling in STK11 mutant lung cancer. Autophagy 16, 1\u201313 (2019).","DOI":"10.1080\/15548627.2019.1634945"},{"key":"2532_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1040-0","volume":"18","author":"Q Lu","year":"2019","unstructured":"Lu, Q. et al. Circular RNA circSLC8A1 acts as a sponge of miR-130b\/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol. Cancer 18, 111 (2019).","journal-title":"Mol. Cancer"},{"key":"2532_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1010-6","volume":"18","author":"X Zheng","year":"2019","unstructured":"Zheng, X. et al. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Mol. Cancer 18, 47 (2019).","journal-title":"Mol. Cancer"},{"key":"2532_CR41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/cancers10080258","volume":"10","author":"M Wang","year":"2018","unstructured":"Wang, M., Yu, F. & Li, P. Circular RNAs: characteristics, function and clinical significance in hepatocellular carcinoma. Cancers (Basel) 10, 258 (2018).","journal-title":"Cancers (Basel)"},{"key":"2532_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/jcm8020171","volume":"8","author":"C Turato","year":"2019","unstructured":"Turato, C. et al. MiR-122 Targets SerpinB3 and is involved in sorafenib resistance in hepatocellular carcinoma. J. Clin. Med. 8, 171 (2019).","journal-title":"J. Clin. Med."},{"key":"2532_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13046-018-1020-z","volume":"38","author":"Y Xie","year":"2019","unstructured":"Xie, Y. et al. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2\/FAK\/Akt pathway. J. Exp. Clin. Cancer Res. 38, 7 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2532_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13046-018-0965-2","volume":"37","author":"Y Zhou","year":"2018","unstructured":"Zhou, Y. et al. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J. Exp. Clin. Cancer Res. 37, 324 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2532_CR45","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13046-018-0957-2","volume":"37","author":"DM Shi","year":"2018","unstructured":"Shi, D. M. et al. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1\/ERBB2\/ERBB3 signaling. J. Exp. Clin. Cancer Res. 37, 294 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2532_CR46","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.biopha.2016.07.037","volume":"83","author":"H Zhu","year":"2016","unstructured":"Zhu, H. et al. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6. Biomed. Pharmacother. 83, 792\u2013797 (2016).","journal-title":"Biomed. Pharmacother."},{"key":"2532_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/path.4495","volume":"236","author":"AY Xing","year":"2015","unstructured":"Xing, A. Y. et al. Catenin-delta1, negatively regulated by miR-145, promotes tumour aggressiveness in gastric cancer. J. Pathol. 236, 53\u201364 (2015).","journal-title":"J. Pathol."},{"key":"2532_CR48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.biopha.2018.06.135","volume":"106","author":"N Cao","year":"2018","unstructured":"Cao, N. et al. MicroRNA-298 represses hepatocellular carcinoma progression by inhibiting CTNND1-mediated Wnt\/beta-catenin signaling. Biomed. Pharmacother. 106, 483\u2013490 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"2532_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13046-016-0344-9","volume":"35","author":"B Tang","year":"2016","unstructured":"Tang, B. et al. Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt\/beta-catenin signaling. J. Exp. Clin. Cancer Res. 35, 82 (2016).","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2532-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2532-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:52:53Z","timestamp":1670251973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2532-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["2532"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2532-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"15 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"340"}}